These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3006848)

  • 1. Biochemical and ultrastructural findings in a lymphoid cell line from Niemann-Pick disease type A.
    Levade T; Salvayre R; Bes JC; Maret A; Douste-Blazy L
    Biol Cell; 1985; 55(1-2):143-6. PubMed ID: 3006848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural investigations on two lymphoid cell lines from Niemann-Pick disease type B.
    Bes JC; Salvayre R; Levade T; Caratero C; Planel H
    Biol Cell; 1984; 50(3):299-302. PubMed ID: 6087964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.
    Levade T; Salvayre R; Bes JC; Nezri M; Douste-Blazy L
    Pediatr Res; 1985 Jan; 19(1):153-7. PubMed ID: 2982124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingomyelinase and nonspecific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.
    Levade T; Salvayre R; Lenoir G; Douste-Blazy L
    Biochim Biophys Acta; 1984 Apr; 793(2):321-4. PubMed ID: 6324871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular forms of sphingomyelinase and non-specific phosphodiesterases in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease types A and B.
    Levade T; Salvayre R; Douste-Blazy L
    Eur J Biochem; 1985 Jun; 149(2):405-9. PubMed ID: 2986976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the activation of sphingomyelinase activity in Niemann-Pick type A, B, and C fibroblasts: enzymological differentiation of types A and B.
    Poulos A; Ranieri E; Shankaran P; Callahan JW
    Pediatr Res; 1984 Nov; 18(11):1088-93. PubMed ID: 6096798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and ultrastructural studies on an Epstein-Barr virus-transformed lymphoid cell line from a Niemann-Pick disease type C patient.
    Levade T; Maret A; Salvayre R; Livni N; Rogalle P; Douste-Blazy L
    Biochim Biophys Acta; 1986 Jul; 877(3):415-22. PubMed ID: 3015220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biochemical diagnostics of Niemann-Pick disease.
    Maciejko D; Tylki-Szymańska A
    Klin Padiatr; 1986; 198(2):103-6. PubMed ID: 3009958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niemann Pick disease: presence of the magnesium-dependent sphingomyelinase in brain of the infantile form of the disease.
    Gatt S; Dinur T; Kopolovic J
    J Neurochem; 1978 Aug; 31(2):547-50. PubMed ID: 209151
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sphingomyelinase activity in a patient with Niemann-Pick disease].
    Sengers RC; Wevers RA; van Haelst UJ; Smeets HL
    Tijdschr Kindergeneeskd; 1989 Apr; 57(2):70-3. PubMed ID: 2545015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dimethylsulfoxide on sphingomyelinase activities in normal and Niemann-Pick type A, B and C fibroblasts.
    Sato M; Yoshida Y; Sakuragawa N; Arima M
    Biochim Biophys Acta; 1988 Sep; 962(1):59-65. PubMed ID: 2843241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms.
    Besley GT; Elleder M
    J Inherit Metab Dis; 1986; 9(1):59-71. PubMed ID: 3014212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingomyelinase isozymes of human tissues: a phpothesis on enzymatic differentiation of the neuropathic and non-neuropathic forms of Niemann-Pick disease.
    Yamaguchi S; Suzuki K
    Biochem Biophys Res Commun; 1977 Aug; 77(3):999-1003. PubMed ID: 197954
    [No Abstract]   [Full Text] [Related]  

  • 15. Sphingomyelinases and Niemann-Pick disease.
    Levade T; Salvayre R; Douste-Blazy L
    J Clin Chem Clin Biochem; 1986 Apr; 24(4):205-20. PubMed ID: 3009683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
    Graber D; Salvayre R; Levade T
    J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific enzymatic diagnosis and ultrastructural analysis of peripheral leukocytes in infantile form of Niemann-Pick sphingomyelinosis.
    László A; Klujber L; Streitmann K; Barb E
    Acta Paediatr Hung; 1990; 30(1):99-105. PubMed ID: 2156543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingomyelinase in cultured skin fibroblasts from normal and Niemann-Pick type C patients.
    Poulos A; Hudson N; Ranieri E
    Clin Genet; 1983 Oct; 24(4):225-33. PubMed ID: 6315279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of dipolar aprotic substances on Niemann-Pick cells.
    Sakuragawa N; Sato M; Kamo I; Arima M
    Acta Paediatr Jpn; 1987 Jun; 29(3):433-40. PubMed ID: 2849855
    [No Abstract]   [Full Text] [Related]  

  • 20. Niemann-Pick disease: prenatal diagnoses and studies of sphingomyelinase activities.
    Wenger DA; Wharton C; Sattler M; Clark C
    Am J Med Genet; 1978; 2(4):345-56. PubMed ID: 233699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.